Repository logo

Impact of Psychotropics on the Gut Microbiota and Potential of Probiotics to Alleviate Related Dysbiosis

dc.contributor.authorAit Chait, Yasmina
dc.contributor.supervisorHammami, Riadh
dc.date.accessioned2021-02-12T19:44:48Z
dc.date.available2022-02-12T10:00:08Z
dc.date.issued2021-02-12en_US
dc.description.abstractThere is an increasing interest in how therapeutic drugs could alter the human gut microbiota composition and function. While some knowledge is accumulating on the antimicrobial impact of some psychotropics on isolated strains or the gut microbiota of animal models, information about other classes of psychotropics and representative species from the human gut is poorly investigated. The antimicrobial effect of psychotropic drugs is usually neglected as a confounding factor when investigating gut microbiome biomarkers, knowing that patients are generally put in long-term medication. The purpose of the present study was to investigate (in vitro and ex-vivo) the antimicrobial activity of some oral commonly prescribed psychotropics from different therapeutic classes on colonic microbiota diversity and metabolism and the potential capacity of probiotics to alleviate related dysbiosis. The findings of this study revealed an important in vitro inhibitory activity of psychotropic drugs, which were also expressed as drastic alterations in gut microbiota composition ex-vivo. Indeed, the relative abundances of Firmicutes and Actinobacteria were lowered while the Proteobacteria population was increased. Families of Lachnospiraceae, Lactobacillaceae, and Erysipelotrichaceae were also declined by psychotropics (aripiprazole) treatment. These microbial changes were translated into a decrease of the major SCFA (butyrate, acetate, and propionate) at the metabolic level. The addition of a probiotic combination (Lactobacillus rhamnosus and Bifidobacterium longum) concomitantly with a psychotropic (aripiprazole) had a protective effect by attenuating the decline of microbiota composition and increasing the concentrations of SCFA. These findings provide evidence that psychotropics, through their antimicrobial effect, have the potential to alter the human gut microbiota composition and metabolism, while probiotics can mitigate the related dysbiosis.en_US
dc.embargo.terms2022-02-12
dc.identifier.urihttp://hdl.handle.net/10393/41766
dc.identifier.urihttp://dx.doi.org/10.20381/ruor-25988
dc.language.isoenen_US
dc.publisherUniversité d'Ottawa / University of Ottawaen_US
dc.subjectGut microbiotaen_US
dc.subjectpsychotropicsen_US
dc.subjectantimicrobial activityen_US
dc.subjectdysbiosisen_US
dc.subjectprobioticsen_US
dc.titleImpact of Psychotropics on the Gut Microbiota and Potential of Probiotics to Alleviate Related Dysbiosisen_US
dc.typeThesisen_US
thesis.degree.disciplineSciences de la santé / Health Sciencesen_US
thesis.degree.levelMastersen_US
thesis.degree.nameMScen_US
uottawa.departmentSciences interdisciplinaires de la santé / Interdisciplinary Health Sciencesen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
Ait_Chait_Yasmina_2021_thesis.pdf
Size:
3.58 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail ImageThumbnail Image
Name:
license.txt
Size:
6.65 KB
Format:
Item-specific license agreed upon to submission
Description: